Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion type Assertion NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_head.
- NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion description "[The BRAF positivity rate by VE1 immunohistochemical analysis in MSI-H colon cancers is consistent with that of published cohorts, which use molecular assays, and the accuracy of positive or negative VE1 staining is high.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_provenance.
- NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion evidence source_evidence_literature NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_provenance.
- NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion SIO_000772 24805134 NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_provenance.
- NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion wasDerivedFrom befree-2016 NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_provenance.
- NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_assertion wasGeneratedBy ECO_0000203 NP1180230.RA2ImYHGorDGp2PrQ7n1HibH7hAhFnDo0L9t0aYr3juvE130_provenance.